Cilostazol and Hydramine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cilostazol (cilostazol) and Hydramine (diphenhydramine hydrochloride). Common drug interactions include urinary tract infection among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Cilostazol and Hydramine. It is created by eHealthMe based on reports of 82 people who take the same drugs from the FDA, and is updated regularly.

What is Cilostazol?

Cilostazol has active ingredients of cilostazol. It is often used in arteriosclerosis of the extremities. eHealthMe is studying from 7,877 Cilostazol users. Check the latest studies of Cilostazol.

What is Hydramine?

Hydramine has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 114,900 Hydramine users. Check the latest studies of Hydramine.

On Jul, 05, 2026

82 people who take Cilostazol and Hydramine together, and have interactions are studied.

Cilostazol and Hydramine drug interactions.

What are the common drug interactions of Cilostazol and Hydramine, by gender? *:

female:

Urinary tract infection
Anaemia (lack of blood)
Hereditary angioedema (recurrent episodes of severe swelling)
Lethargy (tiredness)
Ligament sprain (ligament stretched)
Abdominal pain upper
Anxiety
Back disorder
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Cough

male:

Nausea (feeling of having an urge to vomit)
Skin discolouration (change of skin colour)
Injection site haemorrhage (bleeding from injection site)
Abdominal discomfort
Abdominal distension
Asthenia (weakness)
Dyspnoea (difficult or laboured respiration)
Hypertension (high blood pressure)
Immunoglobulins decreased
Retching (strong involuntary effort to vomit)

What are the common drug interactions of Cilostazol and Hydramine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
Conjunctivitis (pink eye)
Infusion site pain
Injection site erythema (redness at injection site)
Nausea (feeling of having an urge to vomit)
Skin discolouration (change of skin colour)
Weight decreased
Abdominal distension
Immunoglobulins decreased
Retching (strong involuntary effort to vomit)

50-59:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Burning sensation
Cancer pain
Chest pain
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Constipation
Drug intolerance (drug sensitivity)
Dyspnoea (difficult or laboured respiration)
Epididymitis (pain in the scrotum or testicle)
Flushing (the warm, red condition of human skin)

60+:

Pain
Chest discomfort
Anaemia (lack of blood)
Lethargy (tiredness)
Ligament sprain (ligament stretched)
Hypertension (high blood pressure)
Anxiety
Asthenia (weakness)
Back disorder
Cardiac failure congestive

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 18 people, 21.95%
Primary Immunodeficiency Syndrome: 15 people, 18.29%
High Blood Pressure: 14 people, 17.07%
High Blood Cholesterol: 12 people, 14.63%
Nausea (feeling of having an urge to vomit): 12 people, 14.63%
Itching: 10 people, 12.20%
Pain: 10 people, 12.20%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 9 people, 10.98%
Peripheral Vascular Disorder: 9 people, 10.98%
Type 2 Diabetes: 7 people, 8.54%

* Approximation only. Some reports may have incomplete information.

Do you take Cilostazol and Hydramine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously